Elsevier’s ClinicalPath is now a Recognized Quality Solution for the ASCO Certified Program

Elsevier today announced that ClinicalPath, its oncology decision support solution, has been designated a Recognized Quality Solution (RQS) by the Association for Clinical Oncology for the ASCO Certified program, reinforcing its role in advancing high-quality, patient-centered cancer care.

Omry Bigger, President, Clinical Solutions, Elsevier said “Cancer practices want to deliver the best care possible, and this recognition means they can be even more confident in the value ClinicalPath provides. Being able to support cancer practices with their reporting requirements is a crucial element of the RQS designation, and we look forward to taking this step forward with our customers.”

Clifford A. Hudis, MD, FACP, FASCO, CEO of ASCO said, "We are pleased to designate Elsevier's ClinicalPath as a Recognized Quality Solution. ClinicalPath underwent a rigorous validation process that reviewed the necessary data elements for clinical quality measurement and pathway utilization. This recognition demonstrates Elsevier's commitment to assisting practices with meeting certification requirements."

With ClinicalPath, cancer centers can:

• Deliver consistent high-quality, patient-centered care aligned with ASCO Certified standards

• Leverage evidence-based pathways driven by the latest research, updated content, and integrated clinical trials

• Streamline quality reporting and compliance with automated capture of pathway utilization and on/off pathway data

• Enhance credibility and align with payers through support for value-based care models

You can find out more about ClinicalPath here.

About ASCO Certified

ASCO Certified is a practice certification demonstrating oncology patient-centered care based on the Oncology Medical Home (OMH) Standards from the American Society of Clinical Oncology and the Community Oncology Alliance (COA). These standards aim to establish core elements needed to deliver high-quality cancer care and achieve broad consensus among all stakeholders on what patients with cancer should expect and receive from their cancer care teams.

엘스비어 소개

엘스비어는 첨단 정보와 의사결정 지원 분야의 글로벌 선도 기업으로 100년 넘게 과학과 헬스케어의 발전을 지원하며 인류 진보에 기여해 왔습니다. 우리는 170개국 이상에서 학술 및 기업 연구 커뮤니티, 의사, 간호사, 미래의 의료 전문가와 교육자들을 지원합니다. 근거에 기반한 신뢰할 수 있는 과학·의학 콘텐츠와 최첨단 AI 기술을 결합해 중요한 통찰과 혁신적인 솔루션을 제공해, 의미있는 성과를 이루도록 돕고 있습니다. 또한 다양성과 지속 가능성을 제품과 기업 문화 전반에 내재화하며, 우리가 속한 커뮤니티와 협력합니다. 엘스비어 재단은 전 세계에서 연구와 보건 파트너십을 지원합니다.

엘스비어는 전문가 및 기업 고객에게 정보 기반의 분석과 의사결정 도구를 제공하는 글로벌 기업 RELX의 일원입니다. 자세한 내용은 www.elsevier.com에서 확인할 수 있으며, 소셜미디어 @elsevierconnect를 통해 최신 소식을 받아보실 수 있습니다.